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In 1985 when a group of experts convened by the World
Health Organization in Fortaleza, Brazil, met to discuss the
appropriate technology for birth, they echoed what at that
moment was considered an unjustified and remarkable
increase of caesarean section (CS) rates worldwide.1 Based
on the evidence available at that time, the experts in Fort-
aleza concluded: ‘there is no justification for any region to
have a caesarean section rate higher than 10–15%’.1 Over
the years, this quote has become ubiquitous in scientific lit-
erature, being interpreted as the ideal CS rate. Although
this reference range was intended for ‘populations’, which
are defined by geopolitical boundaries, in many instances it
has been mistakenly used as the measurement for health-
care facilities regardless of their complexity or other charac-
teristics. In addition to the case mix of the obstetric
population served, the use of CS at healthcare facilities is
also affected by factors such as their capacity to handle
cases, availability of resource and the clinical management
protocols used locally.
Since its publication and for the last 30 years, this refer-
ence rate for CS has received intense criticism and has led
to controversy, concern, polarised opinions and heated
debates, while in parallel, the use of CS as a mode of deliv-
ery has continued its worrying rise worldwide. The need to
revisit the recommended CS rate has been considered more
and more necessary in view of the significant improve-
ments in clinical obstetric care and in the methodology to
assess evidence and issue recommendations in the last three
decades.
The global concern around CS rates is understandable.
When medically justified, a CS can prevent maternal and
perinatal mortality and morbidity. There is no evidence,
however, showing the benefits of the procedure for women
or infants where it is not required. CS is associated with
short- and long-term risk, which can extend beyond the
current delivery and affect future pregnancies. In addition,
the increase in CS rates seems uncontrollable, with no signs
that it is slowing down. The situation is aggravated by the
fact that the causes of the rise are not fully understood but
emerge as a complex multifactorial labyrinth involving
health systems, health care providers, women, societies, and
even fashion and media.2–6 Lastly, non-clinical interven-
tions to reduce unnecessary CS have shown limited
effectiveness to date.7
In light of these issues, WHO convened a meeting in
Geneva, Switzerland, on 8–9 October 2014 with the objec-
tive of (1) establishing the current WHO position on the
CS rate or range for optimal maternal and perinatal out-
comes at population level, and (2) agreeing on a proposal
for a tool to monitor CS rates at facility level. The State-
ment on Caesarean Section Rates recently released by WHO
summarises the results of the systematic reviews and analy-
ses conducted for this purpose and conveys the thinking
emerging from the discussions of the meeting.8
A systematic review and an ecological analysis were per-
formed and concluded that at population level, CS rates
higher than 10% were not associated with reductions in
maternal and newborn mortality rates.9,10 The Statement
notes, however, that the association between CS rates and
other relevant outcomes such as stillbirths, maternal and
*WHO Working Group on Caesarean Section are in Appendix 1.
667ª 2015 World Health Organization licensed by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License which permits unrestricted use,
distribution and reproduction in any medium, provided that the original work is properly cited.
DOI: 10.1111/1471-0528.13526
www.bjog.org
Commentary
perinatal morbidity, paediatric outcomes and psychological
or social well-being could not be determined due to the
lack of data on these other outcomes at the population
level. This lack of data represents a limitation of these
analyses that needs to be borne in mind.
Beyond numbers and rates, the Statement emphasises
that the critical role played by the quality of care in this
equation cannot be overstated. As with any surgery, CS
is associated with short- and long-term risks, particularly
in settings that lack the facilities or capacity to conduct
safe surgery or treat surgical complications properly, or
where access to labour care or repeat CS in subsequent
pregnancies cannot be taken for granted. On the other
hand, inadequate access to timely CS may result in peri-
natal asphyxia, stillbirth, uterine rupture or obstetric fis-
tula, a marker for exceptionally prolonged, obstructed
labour.11 Thus, CS should be undertaken when medically
necessary, and rather than striving to achieve a specific
rate, efforts should focus on providing caesarean section
to all women in need. How to define the woman ‘in
need’ can only be ascertained by the health care provid-
ers caring for the woman on a case-by-case basis.
Most importantly, at the healthcare facility level, clini-
cians and administrators struggle to monitor CS rates in a
meaningful, reliable and action-oriented manner. Histori-
cally, caesarean sections have often been categorised using
its indications as the unit being classified. Using indica-
tions to classify CS has always been problematic due to the
lack of uniform definitions for most common indications
and has resulted in poor reproducibility and unsatisfactory
comparisons.12 In 2001, Dr Michael Robson proposed a
system of 10 groups that classifies all women admitted for
delivery (and not indications) according to five obstetric
characteristics that are generally routinely collected in most
maternities.13 Two systematic reviews conducted at WHO
identified this classification as the most appropriate system
to fulfil current international and local needs.12,14 The
WHO Statement proposes the use of the Robson classifica-
tion as the global standard for assessing, monitoring and
comparing CS rates within healthcare facilities over time,
and between facilities. In the last decade, this classification
has witnessed an extraordinary expansion in its use world-
wide, particularly in healthcare facilities, due to its intrinsic
appealing characteristics: simplicity of design, validity of
purpose, ease of implementation and directness of initial
interpretation.14 WHO envisions that the information
stemming from the classification can be a powerful tool to
inform practice. The classification will allow not only for
stratification of CS rates in more uniform groups of
women but also the assessment of CS rates in relation to
other perinatal outcomes and processes (e.g. rates of oxyto-
cin usage, postpartum haemorrhage, newborn outcomes,
length of labour).
WHO will guide and support countries in the use,
implementation and interpretation of the classification so
that we can start comparing CS rates in a meaningful, tar-
geted, transparent and useful manner. By endorsing the
Robson classification, this Statement should become a cata-
lyst for action. The time has come to put the debate about
the preferable rate of CS on hold. Let’s start to collect data
uniformly so that in the near future we will be able to
move our focus from CS rates at population level to moni-
toring and discussing CS rates and outcomes in each group
of the Robson classification. Only then will we have the
data and evidence that will lead us more clearly to actions
to improve care.15 Ultimately, we hope the debate can
recommence with more valuable, solid and informative
data to support our discussions.
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